# Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

> **NCT00753116** · PHASE1 · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Failure, Chronic
- Renal Dialysis

## Interventions

- **DEVICE:** Renal Denervation with a catheter-based procedure

## Key facts

- **NCT ID:** NCT00753116
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00753116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00753116, "Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00753116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
